Webb8 okt. 2024 · Background: Etoposide plus platinum-based chemotherapy (EP) was the first-line (1L) extensive stage small cell lung cancer (ES-SCLC) standard of care for many … Webb27 dec. 2024 · In this Expert Review, leading experts in the field discuss the current standard of care for ES SCLC, as well as examining the biology of SCLC and molecular …
Durvalumab: A Review in Extensive-Stage SCLC SpringerLink
Webb13 maj 2024 · For decades, the standard of care for ES-SCLC was platinum and etoposide combination chemotherapy, with the incorporation of immune checkpoint blockade into frontline treatment only after 2024. 7, 8 There has been recent progress in recognizing distinct subtypes of SCLC using transcriptional profiling and multiple novel targeted … WebbThe addition of atezo to carboplatin and etoposide continued to provide improvement in OS for 1L ES-SCLC. These results further support this regimen as the new standard of care … god\u0027s christmas tree
After Decades, New Standard of Care in Small Cell Lung Cancer
Webb16 dec. 2024 · PD-1/PD-L1 inhibitors offer an improvement over standard of care in SCLC, but there is still a long way to go. In March 2024, atezolizumab, a programmed cell death … Webbextensive-stage SCLC (ES-SCLC). For limited-stage disease, RT is used for the curative-intent treatment ... For patients with LS-SCLC, involved-field RT is recommended as the standard of care (defined as fluorodeoxyglucose avid on PET, enlarged on CT, and/or biopsy-positive) (Strength of recommendation: strong; Quality of Webb14 mars 2024 · In March 2024, AstraZeneca’s Imfinzi has been FDA approved in the United States as the first-line treatment for adult patients with Extensive-Stage Small Cell Lung … book nothing lasts forever wikipedia